Tori Elizabeth Branch, PSYD | |
9060 Graton Rd Uppr Floor, Graton, CA 95444-9364 | |
(415) 375-0763 | |
Not Available |
Full Name | Tori Elizabeth Branch |
---|---|
Gender | Female |
Speciality | Clinical Psychologist |
Experience | 13 Years |
Location | 9060 Graton Rd Uppr Floor, Graton, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972880219 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | PSY25773 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Tori Elizabeth Branch, PSYD 9060 Graton Rd Uppr Floor, Graton, CA 95444-9364 Ph: (415) 375-0763 | Tori Elizabeth Branch, PSYD 9060 Graton Rd Uppr Floor, Graton, CA 95444-9364 Ph: (415) 375-0763 |
News Archive
Air pollution is a major public health issue worldwide. Filters can help improve the quality of the air we breathe, but they also contribute to landfill when they are finished with and thrown away, as they are often made of plastic.
Britain's Naional Heath Service is being taken over by big business so that money that could go towards clinical care is diverted to corporations and their shareholders, warn two senior doctors in this week's British Medical Journal.
Scheibye-Knudsen Lab, University of Copenhagen and Deep Longevity are excited to reveal the speakers for the 8th Aging Research & Drug Discovery Meeting, the largest scientific academic, and industry conference that will transpire on August 31 - September 3, 2021, on-site at the Ceremonial Hall, University of Copenhagen, and online.
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients who received the targeted therapy sunitinib (Sutent), regardless of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk group, according to new analysis of the CheckMate-214 clinical trial.
› Verified 1 days ago